You are here

  • Home
  • Archive
  • Volume 11, Issue 6
  • Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma

 

Online download statistics by month:

Online download statistics by month: June 2023 to July 2025

AbstractFullPdf
Jun 2023527544138
Jul 202317317430
Aug 202326226624
Sep 202310610629
Oct 2023707034
Nov 2023838420
Dec 2023616325
Jan 2024767842
Feb 2024525226
Mar 2024656779
Apr 2024444431
May 2024424634
Jun 2024464529
Jul 2024818336
Aug 2024373824
Sep 2024292929
Oct 2024404025
Nov 2024252713
Dec 2024333513
Jan 2025353526
Feb 2025393936
Mar 2025515131
Apr 2025686831
May 2025272816
Jun 202521216
Jul 2025110
Total20942134827